07U64JZ
Supplement Lymphatic, Left Axillary to No Qualifier with Synthetic Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 7 Lymphatic and Hemic Systems |
| Operation | U Supplement |
| Body Part | 6 Lymphatic, Left Axillary |
| Approach | 4 Percutaneous Endoscopic |
| Device | J Synthetic Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
This family covers procedures where a surgeon places biological or synthetic material onto or into a structure of the lymphatic and hemic system to reinforce it or bolster a function that has been weakened, most often after injury. The leading example is splenic salvage surgery: when the spleen has been lacerated in blunt abdominal trauma, wrapping it in absorbable mesh compresses the injured tissue and supports it while it heals, allowing the surgeon to avoid removing the organ altogether. Patients benefit because the spleen filters blood and helps fight certain bacteria, so keeping it intact lowers the lifetime risk of severe infection that follows a splenectomy.
The material itself is not doing the healing directly; it is holding tissue together and adding structural support so that the body's own repair processes can proceed without the organ falling apart or re-bleeding. Outside of splenic trauma, this family sees limited use elsewhere in the lymphatic system, since lymph nodes and channels are rarely reinforced with an implanted product.
Anatomy & Axis Detail
Lymphatic, Left Axillary
The left axillary lymph nodes form the principal drainage basin for the left arm and lateral chest, and this region is commonly compromised after axillary lymph node dissection or radiotherapy, most often in the setting of left-sided breast cancer treatment. Supplement here describes reinforcing the residual lymphatic tissue, frequently through vascularized lymph node transfer, to enhance drainage capacity in patients who have gone on to develop arm lymphedema despite conservative management. The previously operated or irradiated axilla presents dense fibrotic tissue that makes precise identification of vessels and nerves more demanding during reconstruction. Coders should verify that the procedure preserved existing left axillary lymphatic structures while adding supportive material, which is the key distinction that places this case under Supplement rather than a full structural replacement.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Synthetic Substitute
Synthetic Substitute designates a device made from manufactured, non-biologic material, such as mesh or prosthetic components, used to replace or augment a body part. It is distinguished from the two tissue substitute categories by its artificial composition, which carries different considerations for integration and long-term durability than biologic grafts.
Coding & Documentation
A coder should look for documentation that a mesh, wrap, or similar reinforcing material was left in place around an existing structure, most commonly the spleen, distinguishing it from a laceration that was simply sutured closed. The operative note needs to specify both the material used and that it augments rather than replaces the organ. The most frequent error is defaulting to Repair whenever a splenic injury is fixed surgically, when the presence of a retained mesh wrap actually calls for Supplement with the correct device value recorded.